$BPTH skyrockets on Received Third U.S. Patent Grant
Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology
Provides Expanded Protection to Seminal Patents Related to DNAbilize
The new patent builds on earlier patents granted that protect the platform technology for DNAbilize®, the Company’s novel RNAi nanoparticle drugs.
finance.yahoo.com/news/bio-path-receives-third-u-120000403.html
Provides Expanded Protection to Seminal Patents Related to DNAbilize
The new patent builds on earlier patents granted that protect the platform technology for DNAbilize®, the Company’s novel RNAi nanoparticle drugs.
finance.yahoo.com/news/bio-path-receives-third-u-120000403.html
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.